How do I add an epinephrine (epi) drip to a patient on levophed (norepinephrine) at 30mcg/min in the setting of profound and acute hypotension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Adding Epinephrine to High-Dose Norepinephrine in Profound Hypotension

Start an epinephrine infusion at 0.1-0.5 mcg/kg/min (7-35 mcg/min in a 70 kg adult) when norepinephrine reaches 0.25 mcg/kg/min (approximately 17.5 mcg/min or 1.05 mg/h in a 70 kg patient) and hypotension persists, while ensuring adequate fluid resuscitation with at least 30 mL/kg crystalloid bolus has been administered. 1

Critical Pre-Requirements Before Adding Epinephrine

  • Verify adequate volume resuscitation first - you must have given at least 30 mL/kg crystalloid bolus before or concurrent with vasopressor escalation, as vasoconstriction in hypovolemic patients causes severe organ hypoperfusion despite "normal" blood pressure 1, 2

  • Confirm central venous access - both norepinephrine and epinephrine should be administered through central venous access to minimize extravasation risk and tissue necrosis 1, 3

  • Place arterial line immediately if not already present for continuous blood pressure monitoring during dual vasopressor therapy 1

Epinephrine Preparation and Initial Dosing

  • Standard concentration: Add 4 mg epinephrine to 250 mL D5W to yield 16 mcg/mL (same concentration preparation as norepinephrine) 1

  • Starting dose: Begin at 0.1 mcg/kg/min (7 mcg/min in a 70 kg adult, which equals approximately 26 mL/h with standard 16 mcg/mL concentration) 1

  • Alternative for anaphylaxis context: If the profound hypotension is anaphylaxis-related, prepare 1 mg epinephrine in 100 mL saline (1:100,000 solution) and start at 30-100 mL/h (5-15 mcg/min) 2

Titration Protocol for Epinephrine

  • Monitor blood pressure and heart rate every 5-15 minutes during initial titration 1

  • Target MAP of 65 mmHg as your primary endpoint, while also assessing tissue perfusion markers: lactate clearance, urine output >50 mL/h, mental status, and capillary refill 1, 3

  • Titrate upward by doubling the dose every 15 minutes if inadequate response, up to maximum 0.5 mcg/kg/min (35 mcg/min in 70 kg adult) 1, 2

  • Do NOT increase epinephrine beyond 0.5 mcg/kg/min - instead add additional agents (see below) 1

Simultaneous Management of Norepinephrine

  • Continue norepinephrine at current dose (30 mcg/min) when initiating epinephrine - do not decrease it 1

  • Consider adding vasopressin 0.03-0.04 units/min as third-line agent if MAP remains <65 mmHg despite norepinephrine 0.25 mcg/kg/min plus epinephrine 1

  • Do NOT increase vasopressin above 0.04 units/min - reserve higher doses only for salvage therapy 1

Critical Monitoring Parameters

  • Assess for excessive vasoconstriction: cold extremities, decreased urine output, rising lactate despite adequate MAP 1

  • Watch for tachyarrhythmias - epinephrine has more beta-1 activity than norepinephrine and increases risk of arrhythmias, particularly at higher doses 3, 2

  • Monitor for increased myocardial oxygen demand - epinephrine significantly increases heart rate and contractility, which may precipitate ischemia in susceptible patients 3

  • Do NOT mix epinephrine with sodium bicarbonate or alkaline solutions in the IV line, as epinephrine is inactivated in alkaline solutions 2

When to Add Inotropic Support Instead

  • If evidence of myocardial dysfunction exists (low cardiac output on echo, elevated troponin, known cardiomyopathy), consider adding dobutamine 2.5-20 mcg/kg/min rather than escalating epinephrine further 1

  • Start dobutamine at 2.5 mcg/kg/min and double every 15 minutes based on response, with dose titration usually limited by excessive tachycardia, arrhythmias, or ischemia 1

Common Pitfalls to Avoid

  • Never add epinephrine without ensuring adequate fluid resuscitation - this is the most critical error, as vasopressors in hypovolemic patients worsen organ perfusion 1, 4

  • Do not use dopamine as an alternative - it is associated with higher mortality and more arrhythmias compared to norepinephrine/epinephrine 1

  • Avoid phenylephrine as first-line alternative - it may raise blood pressure while worsening tissue perfusion due to pure alpha-agonism without beta effects 1

  • Do not delay epinephrine addition if norepinephrine is already at 30 mcg/min (>0.25 mcg/kg/min in most adults) - you are already past the threshold for adding second-line agents 1

Special Consideration for Your Specific Scenario

At 30 mcg/min norepinephrine (approximately 0.43 mcg/kg/min in a 70 kg patient), you are already well above the 0.25 mcg/kg/min threshold where guidelines recommend adding epinephrine 1. The profound and acute nature of your patient's hypotension suggests either:

  1. Inadequate volume resuscitation - verify 30 mL/kg crystalloid given 1
  2. Distributive shock component - epinephrine addition is appropriate 1
  3. Cardiogenic component - consider dobutamine instead if myocardial dysfunction present 1

Start the epinephrine infusion immediately at 0.1 mcg/kg/min while simultaneously reassessing volume status and considering vasopressin as third-line agent. 1

References

Guideline

Norepinephrine Drip Administration Protocol

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Epinephrine Dosing for Hypotension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Norepinephrine Dosing for Hypotension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.